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Objectives: to evaluate the plasma IL-10 levels during elective operative repair of thoraco-abdominal and abdominal
aortic aneurysm repair. To study whether IL-10 plasma levels are associated with the duration of cross-clamping
(ischaemia) and clinical outcome.
Materials: fifteen consecutive patients undergoing surgery for TAAA and 10 consecutive patients undergoing surgical
repair of AAA were included.
Methods: plasma concentrations of IL-10 were measured by ELISA technique. Clinical outcome of the TAAA patients
was prospectively analysed.
Results: during aortic clamping IL-10 was produced in both populations. The plasma IL-10 peak (934±172 pg/ml) of
the TAAA group was seen at 4 h after declamping and remained detectable after 48 h. The plasma IL-10 peak (212±32 pg/
ml) of the AAA group was seen 30 min after declamping and fell to undetectable levels by 24 h. These data show that
the peak IL-10 plasma levels in TAAA repair are significantly (p<0.05) higher compared to the peak IL-10 plasma levels
as seen during AAA repair. A positive correlation was seen between cross-clamping and peak plasma IL-10 and organ
dysfunction.
Conclusions: IL-10 plasma concentrations appear higher, later and are longer detectable in patients undergoing TAAA.
Correlations were seen with duration of cross-clamping and MSOD.
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Introduction Animal studies have demonstrated that gastro-
intestinal ischaemia-reperfusion injury provokes the
release of pro-inflammatory cytokines, particularly IL-Aneurysmal disease most commonly involves the
1 and TNF.8 Patients undergoing thoraco-abdominalinfrarenal aorta and less frequently the thoracic and/or
aortic aneurysm repair release IL-1, TNF and IL-8suprarenal abdominal aorta. While repair of infrarenal
systemically.9 An array of anti-inflammatory cytokinesabdominal aortic aneurysms (AAA) results in an op-
and cytokine inhibitors regulates the production anderative mortality of 2–5%,1 repair of thoraco-abdominal
function of the pro-inflammatory cytokines. These in-aortic aneurysms results in significantly higher rates of
clude IL-1 receptor antagonist (IL-1ra), the shed typemortality (5–25%).2,3 In addition, patients undergoing
I (p55) and type II (p75) TNF receptors, the shed typeoperative repair of thoraco-abdominal aortic aneurysm
II IL-1 receptor, IL-4, IL-10, and IL-13. Of particularexperience an increased frequency of pulmonary dys-
interest is IL-10, a pleiotropic cytokine that regulatesfunction (20–47%), renal dysfunction (20–30%), and
both macrophage and T-cell function. Specifically, IL-spinal cord injury (5–15%).4–6 These high rates of mor-
10 has been demonstrated to inhibit the production ofbidity and mortality may be related to gastrointestinal
IL-1, IL-1, IL-8, and TNF by macrophages stim-ischaemia-reperfusion injury secondary to the sup-
ulated with LPS in vitro.10 Exogenous administrationrarenal cross-clamping.7
of recombinant IL-10 has been demonstrated to protect
against lethal endotoxaemia,11,12 has reduced local and
systemic inflammation in an intestinal ischaemia/re-
∗ Please address all correspondence to: P. A. M. van Leeuwen,
perfusion model,13 and has reduced injury in a hin-Department of Surgery, University Hospital Vrije Universiteit, De
Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. dlimb ischaemia/reperfusion model.14 Endogenously
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produced IL-10 attenuates the inflammatory response
to a mixed flora peritonitis.15
The aim of this study was to compare plasma IL-10
levels following abdominal and thoraco-abdominal
aortic aneurysm repair and to determine whether this
correlates with the ischaemia/reperfusion injury and
organ dysfunction.
Methods
Fifteen consecutive patients undergoing thoraco-ab-
dominal aortic aneurysm repair and 10 consecutive
patients undergoing infrarenal abdominal aortic an-
eurysm repair were evaluated. Informed consent was
obtained from each patient and experimental protocols
were approved by the institutional review boards at
University Hospital Vrije Universiteit, Amsterdam and
Fig. 1. Mean plasma IL-10 concentrations vs. time for patientsThe University of Florida College of Medicine. Arterial
undergoing abdominal aortic aneurysm (AAA) repair (Β) andblood was assayed immediately preoperatively, before thoraco-abdominal aortic aneurysm (TAAA) repair (Χ). One hour
the placement of the aortic cross-clamp, immediately prior to surgery (T=−1), time of clamp on (T=−0.5), clamp off
(T=−0.25), time of closure (T=0) and the postoperative times (T=after removal of the cross-clamp and at specific time
2, T=4, T=6 and T=24). In the AAA patients, the IL-10 peakintervals following reperfusion (0, 2, 4, 6, 24 and 48 h). occurred 30 min after aortic declamping and the plasma con-
Blood was collected in sterile glass tubes containing centration fell to undetectable levels by 24 h. In the TAAA patients,
the IL-10 peak occurred after 4 h of reperfusion and did not decreaseEDTA, chilled immediately, then centrifuged at
to undetectable levels until after 48 h of reperfusion.2000 rpm for 10 min. The plasma portion was then ∗ p<0.05.
removed, placed into sterile 1.5 ml tubes, and stored
at−70 °C until analyses were performed. Plasma con-
centrations of IL-10 were measured by ELISA using
produced IL-10 after reperfusion in a monophasicreagents provided by Schering Research Laboratories,
fashion (Fig. 1). Peak levels of IL-10 after thoraco-Kenilworth, NJ, U.S.A.
abdominal aortic aneurysm repair were over four-foldThe clinical outcome of the patients undergoing
higher than after abdominal aortic aneurysm repairthoraco-abdominal aortic aneurysm repair was pro-
(943±172 pg/ml vs. 212±32 pg/ml, respectively)spectively analysed. Organ dysfunction was defined
(p<0.05). In the abdominal aortic aneurysm patients,as follows: pulmonary dysfunction – the requirement of
the IL-10 peak occurred 30 min after aortic declampingpositive-pressure ventilation for >7 days; renal dys-
and fell to undetectable levels by 24 h. In contrast,function – an increase in serum creatinine of >2 mg/
peak IL-10 concentrations occurred after 4 h of re-dl from the preoperative value; hepatic dysfunction
perfusion in the thoraco-abdominal aortic aneurysm– an LDH of >500 U/l and an AST >200 U/l; and
patients and did not decrease to undetectable levelshaematopoietic dysfunction – development of a platelet
until after 48 h of reperfusion.count <50 000/mm3. Patients with dysfunction of two
In the patients undergoing thoraco-abdominal aorticor more organ systems were considered to have multi-
aneurysm repair, IL-10 levels directly correlated withsystem organ dysfunction (MSOD).
organ dysfunction and longer aortic cross-clamp timesData are expressed as means±standard error of the
(p<0.05) (Table 1). Patients with IL-10 concentrationsmean. Statistical significance was determined by two-
>950 pg/ml after 4 h of reperfusion were more likelyway ANOVA, Fisher’s exact test, Pearson’s correlation,
to experience hepatic, haemopoietic and multi-systemand Student’s t-test with a p value of less than 0.05
organ dysfunction. There were also higher rates of(two-tailed) being considered significant.
pulmonary and renal dysfunction in these patients,
although these were not statistically significant.
Patients with IL-10 concentrations >950 pg/ml at 4 hResults
also had significantly longer gastrointestinal ischaemic
times as determined by supracoeliac aortic cross-clampThe patients undergoing both abdominal aortic an-
eurysm and thoraco-abdominal aortic aneurysm repair times (60 min vs. 36 min, p<0.05).
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Table 1. Organ dysfunction and aortic cross-clamp time vs. IL- concentrations may partially contribute to the
10 concentrations measured at 4 h after cross-clamp removal in immunosuppressive response that occurs several dayspatients undergoing thoraco-abdominal aortic aneurysm repair
(MSOD=multi-system organ dysfunction). after major operative trauma.20 Conversely, the in-
creased endogenous IL-10 response could (indirectly)
IL-10 <950 pg/ IL-10 >950 pg/ reflect an exaggerated pro-inflammatory cytokine re-ml ml
(n=8) (n=7) sponse, in toto, since we have previously reported
that patients undergoing thoraco-abdominal aneurysm
MSOD 13% 86%∗ repair also have elevated plasma levels of TNF andPulmonary dysfunction 25% 71%
Renal dysfunction 25% 57% IL-1.9 The systemic IL-10 response to ischaemia-
Hepatic dysfunction 0% 86% reperfusion injury could be a counter-regulatory mech-
Haematopoietic dysfunction 13% 71% anism intended to attenuate the subsequent pro-Supracoeliac cross-clamp 36 min 60 min∗∗
time duction of systemic pro-inflammatory cytokines, such
as TNF and IL-1.21 A similar response occurs in septic
∗ p<0.05 vs. Fisher’s exact test. mice as blocking the endogenous IL-10 response∗∗ p<0.05 by t-test.
under these conditions exacerbates the tissue injury.15,22
It may well be that augmentation of the IL-10 response
Discussion in patients undergoing thoraco-abdominal aortic an-
eurysm repair by administering recombinant protein
The present study demonstrates that IL-10 is produced perioperatively may result in organ protection and a
after ischaemia-reperfusion injury secondary to elect- decreased rate of organ dysfunction in the post-
ive abdominal aortic and thoraco-abdominal aortic operative period.23,24
aneurysm repair. In a recent study a similar IL-10 The present study confirms IL-10 production fol-
pattern was reported in patients undergoing ab- lowing the two types of aneurysm repair and supports
dominal aneurysm repair compared to controls.16 IL- the concept that there is an association between the
10 levels have also been reported by others to be extent of operative injury including visceral isch-
elevated in patients with sepsis.15,17–19 aemia/reperfusion and IL-10 plasma concentrations.
The elevation in plasma IL-10 levels seen after Within its limitations we consider the correlation of
gastrointestinal ischaemia-reperfusion injury and op- IL-10 plasma levels and multi-system organ dys-
erative trauma secondary to thoraco-abdominal aortic function as very interesting for future investigation.
aneurysm repair is greater and of longer duration
than that observed after infrarenal abdominal aortic
aneurysm repair. The infrarenal abdominal aortic an-
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